Contact
Please use this form to send email to PR contact of this press release:
Teligent, Inc. Announces FDA Approval of Halobetasol Propionate Ointment, 0.05%
TO:
Please use this form to send email to PR contact of this press release:
Teligent, Inc. Announces FDA Approval of Halobetasol Propionate Ointment, 0.05%
TO: